DSM Anti-Infectives enters into partnership with Indian company Arch Pharmalabs Ltd.

10-Dec-2007

DSM anti-infectives, a business group of Royal DSM N.V., and Arch Pharmalabs Ltd. have signed a partnership agreement. In the partnership DSM Anti-Infectives will contribute its innovative fermentative technologies and market access to the partnership, whereas Arch will utilize its asset base in India and its competences in chemical conversion.

"This will accelerate the development of new products for DSM Anti-Infectives" commented Gerard de Reuver, Business Group Director DSM Anti-Infectives.

As announced in June 2007, DSM Anti-Infectives is currently rationalizing its portfolio and actively looking for partnerships. A part of the current portfolio (such as clavulanic acid) will be divested and new products will be developed.

Other news from the department business & finance

Most read news

More news from our other portals

Discover the latest developments in battery technology!